Recent Updates
Recently added Catalysts
MDAI Positive Sentiment Score: 70/100

Spectral AI Schedules 2023 Third Quarter Financial Results and Conference Call

Key Takeaway: Spectral AI, Inc. has announced that it will report its third quarter financial results for 2023 on November 13, following which it will hold a conference call on November 14. The company specializes in artificial intelligence for medical diagnostics to improve wound care treatment decisions, particularly for burns and diabetic foot ulcers. Spectral AI aims to significantly enhance current treatment standards with its DeepView® System, which offers objective assessments of wound healing potential.

Market Sentiment Analysis

POSITIVE FACTORS

  • Spectral AI is focused on innovative AI-driven medical diagnostics.
  • The DeepView® System aims to improve patient outcomes in wound care.
  • The upcoming financial results may reflect positive growth.
  • The company is hosting an informative conference call for investors.

Full Press Release Details

DALLAS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2023 on Monday, November 13, 2023 after the close of the stock market. The Company will host a conference call on Tuesday, November 14, 2023 at 9:00 am Eastern Time to discuss the results.
Investors interested in participating in the live call can dial:
412-317-1837 - International
A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of substantially exceeding the current standard of care in the future, DeepView® is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView®, visit www.spectral-ai.com.
Devin Sullivan, Managing Director
Conor Rodriguez, Analyst
Guillermo Ruiz, M.D., Ph.D.

Frequently Asked Questions

When will Spectral AI report its third-quarter financial results?

Spectral AI will report its third-quarter financial results on November 13, 2023.

What time is the financial results conference call?

The conference call to discuss the results will be on November 14, 2023, at 9:00 am ET.

How can I access the conference call webcast?

The webcast can be accessed from the Events & Presentations section of the Investor Relations page.

What is the focus of Spectral AI's DeepView® System?

The DeepView® System focuses on improving wound care diagnostics for better treatment decisions.

What types of patients does DeepView® initially serve?

DeepView® initially serves patients with burns and diabetic foot ulcers.

Last updated: Nov 1, 2023